These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17449889)

  • 1. In vitro and in vivo antibacterial evaluation of DRF 8417, a new oxazolidinone.
    Sreenivas K; Amarnath PV; Mallik A; Sarnaik H; Kumar NS; Takhi M; Trehan S; Kumar MS; Iqbal J; Rajagopalan R; Chakrabarti R
    J Antimicrob Chemother; 2007 Jul; 60(1):159-61. PubMed ID: 17449889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
    Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activities of DA-7867, a new oxazolidinone, against aerobic gram-positive bacteria.
    Yoon EJ; Jo YW; Choi SH; Lee TH; Rhee JK; Yoo M; Shim MJ; Choi EC
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2498-500. PubMed ID: 15917554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linezolid in vitro: mechanism and antibacterial spectrum.
    Livermore DM
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii9-16. PubMed ID: 12730138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent.
    Takhi M; Murugan C; Munikumar M; Bhaskarreddy KM; Singh G; Sreenivas K; Sitaramkumar M; Selvakumar N; Das J; Trehan S; Iqbal J
    Bioorg Med Chem Lett; 2006 May; 16(9):2391-5. PubMed ID: 16488606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.
    Zhou J; Bhattacharjee A; Chen S; Chen Y; Duffy E; Farmer J; Goldberg J; Hanselmann R; Ippolito JA; Lou R; Orbin A; Oyelere A; Salvino J; Springer D; Tran J; Wang D; Wu Y; Johnson G
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6175-8. PubMed ID: 18947996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with linezolid therapy in children with osteoarticular infections.
    Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
    Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations.
    Jones RN; Ross JE; Fritsche TR; Sader HS
    J Antimicrob Chemother; 2006 Feb; 57(2):279-87. PubMed ID: 16326811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
    Balkhy HH; Memish ZA; Shibl A; Elbashier A; Osoba A
    East Mediterr Health J; 2005; 11(1-2):36-44. PubMed ID: 16532669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT; Liao CH; Teng LJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
    Roveta S; Marchese A; Debbia EA
    Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis.
    Genin MJ; Hutchinson DK; Allwine DA; Hester JB; Emmert DE; Garmon SA; Ford CW; Zurenko GE; Hamel JC; Schaadt RD; Stapert D; Yagi BH; Friis JM; Shobe EM; Adams WJ
    J Med Chem; 1998 Dec; 41(26):5144-7. PubMed ID: 9857083
    [No Abstract]   [Full Text] [Related]  

  • 15. Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis.
    Genin MJ; Allwine DA; Anderson DJ; Barbachyn MR; Emmert DE; Garmon SA; Graber DR; Grega KC; Hester JB; Hutchinson DK; Morris J; Reischer RJ; Ford CW; Zurenko GE; Hamel JC; Schaadt RD; Stapert D; Yagi BH
    J Med Chem; 2000 Mar; 43(5):953-70. PubMed ID: 10715160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey.
    Gonullu N; Catal F; Kucukbasmaci O; Ozdemir S; Torun MM; Berkiten R
    Chemotherapy; 2009; 55(3):161-7. PubMed ID: 19390189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biaryl oxazolidinones: in vitro and in vivo activities with pharmacokinetics in an animal model.
    Barman TK; Pandya M; Mathur T; Bhadauriya T; Rao M; Khan S; Singhal S; Bhateja P; Sood R; Malhotra S; Das B; Paliwal J; Bhatnagar PK; Upadhyay DJ
    Int J Antimicrob Agents; 2009 Mar; 33(3):280-4. PubMed ID: 19091517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
    Pal RB; Pal P; Jain S; Kulkarni KP
    J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antibacterial activity of new N-linked 5-triazolylmethyl oxazolidinones.
    Phillips OA; Udo EE; Ali AA; Samuel SM
    Bioorg Med Chem; 2005 Jun; 13(12):4113-23. PubMed ID: 15911326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of YC-20, a new oxazolidinone.
    Cui Y; Dang Y; Yang Y; Zhang S; Ji R
    J Antimicrob Chemother; 2006 Aug; 58(2):452-4. PubMed ID: 16807251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.